THE Department of Health has published indicative 01 Oct 2017 prices resulting from the 2017 October Cycle of Price Disclosure.
The price reductions range from 37% at the top end for lamivudine tablets, through to 34% for quetiapine, 33% for pramipexole, 31% for temolzolomide, 28% for capecitabine, 24% for aolanzapine, 23% for letrozole, 22% for telmisartan and zolmitriptan, 21% for rabeprazole, filgrastim and granisetron, down to 10% for esomeprazole, irbesartan, perindopril and lercanidipine.
There are also price cuts of up to 94% for some medications under the Efficient Funding of Chemotherapy initiative - pbs.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 17 Jul 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Jul 17